Benchmark Has Lowered Expectations for Harvard Bioscience (NASDAQ:HBIO) Stock Price
Harvard Bioscience (NASDAQ:HBIO – Get Free Report) had its target price lowered by Benchmark from $5.50 to $4.50 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “speculative buy” rating on the medical instruments supplier’s stock. Harvard Bioscience Stock Down 1.1 % Shares of Harvard Bioscience stock opened at $0.59 […]
Harvard Bioscience (NASDAQ:HBIO – Get Free Report) had its target price lowered by Benchmark from $5.50 to $4.50 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “speculative buy” rating on the medical instruments supplier’s stock. Harvard Bioscience Stock Down 1.1 % Shares of Harvard Bioscience stock opened at $0.59 […]
